Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data
Abstract Background Liver cancer remains the leading cause of cancer death globally, and the treatment strategies are distinct for each type of malignant hepatic tumors. However, the differential diagnosis before surgery is challenging and subjective. This study aims to build an automatic diagnostic...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-021-01167-2 |
id |
doaj-df89ff64a65149f094eb41641bd92ac6 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ruitian Gao Shuai Zhao Kedeerya Aishanjiang Hao Cai Ting Wei Yichi Zhang Zhikun Liu Jie Zhou Bing Han Jian Wang Han Ding Yingbin Liu Xiao Xu Zhangsheng Yu Jinyang Gu |
spellingShingle |
Ruitian Gao Shuai Zhao Kedeerya Aishanjiang Hao Cai Ting Wei Yichi Zhang Zhikun Liu Jie Zhou Bing Han Jian Wang Han Ding Yingbin Liu Xiao Xu Zhangsheng Yu Jinyang Gu Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data Journal of Hematology & Oncology Artificial intelligence Liver cancer Contrast-enhanced CT Computer-assisted diagnosis Multimodal data |
author_facet |
Ruitian Gao Shuai Zhao Kedeerya Aishanjiang Hao Cai Ting Wei Yichi Zhang Zhikun Liu Jie Zhou Bing Han Jian Wang Han Ding Yingbin Liu Xiao Xu Zhangsheng Yu Jinyang Gu |
author_sort |
Ruitian Gao |
title |
Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data |
title_short |
Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data |
title_full |
Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data |
title_fullStr |
Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data |
title_full_unstemmed |
Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data |
title_sort |
deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced ct and clinical data |
publisher |
BMC |
series |
Journal of Hematology & Oncology |
issn |
1756-8722 |
publishDate |
2021-09-01 |
description |
Abstract Background Liver cancer remains the leading cause of cancer death globally, and the treatment strategies are distinct for each type of malignant hepatic tumors. However, the differential diagnosis before surgery is challenging and subjective. This study aims to build an automatic diagnostic model for differentiating malignant hepatic tumors based on patients’ multimodal medical data including multi-phase contrast-enhanced computed tomography and clinical features. Methods Our study consisted of 723 patients from two centers, who were pathologically diagnosed with HCC, ICC or metastatic liver cancer. The training set and the test set consisted of 499 and 113 patients from center 1, respectively. The external test set consisted of 111 patients from center 2. We proposed a deep learning model with the modular design of SpatialExtractor-TemporalEncoder-Integration-Classifier (STIC), which take the advantage of deep CNN and gated RNN to effectively extract and integrate the diagnosis-related radiological and clinical features of patients. The code is publicly available at https://github.com/ruitian-olivia/STIC-model . Results The STIC model achieved an accuracy of 86.2% and AUC of 0.893 for classifying HCC and ICC on the test set. When extended to differential diagnosis of malignant hepatic tumors, the STIC model achieved an accuracy of 72.6% on the test set, comparable with the diagnostic level of doctors’ consensus (70.8%). With the assistance of the STIC model, doctors achieved better performance than doctors’ consensus diagnosis, with an increase of 8.3% in accuracy and 26.9% in sensitivity for ICC diagnosis on average. On the external test set from center 2, the STIC model achieved an accuracy of 82.9%, which verify the model’s generalization ability. Conclusions We incorporated deep CNN and gated RNN in the STIC model design for differentiating malignant hepatic tumors based on multi-phase CECT and clinical features. Our model can assist doctors to achieve better diagnostic performance, which is expected to serve as an AI assistance system and promote the precise treatment of liver cancer. |
topic |
Artificial intelligence Liver cancer Contrast-enhanced CT Computer-assisted diagnosis Multimodal data |
url |
https://doi.org/10.1186/s13045-021-01167-2 |
work_keys_str_mv |
AT ruitiangao deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT shuaizhao deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT kedeeryaaishanjiang deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT haocai deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT tingwei deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT yichizhang deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT zhikunliu deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT jiezhou deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT binghan deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT jianwang deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT handing deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT yingbinliu deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT xiaoxu deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT zhangshengyu deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata AT jinyanggu deeplearningfordifferentialdiagnosisofmalignanthepatictumorsbasedonmultiphasecontrastenhancedctandclinicaldata |
_version_ |
1716845689310281728 |
spelling |
doaj-df89ff64a65149f094eb41641bd92ac62021-10-03T11:03:46ZengBMCJournal of Hematology & Oncology1756-87222021-09-011411710.1186/s13045-021-01167-2Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical dataRuitian Gao0Shuai Zhao1Kedeerya Aishanjiang2Hao Cai3Ting Wei4Yichi Zhang5Zhikun Liu6Jie Zhou7Bing Han8Jian Wang9Han Ding10Yingbin Liu11Xiao Xu12Zhangsheng Yu13Jinyang Gu14Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong UniversityDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong UniversityDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong UniversityDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Biliary-Pancreatic Surgery, Renji Hospital Affiliated To Shanghai Jiao Tong University School of MedicineDepartment of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineDepartment of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong UniversityDepartment of Transplantation, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of MedicineAbstract Background Liver cancer remains the leading cause of cancer death globally, and the treatment strategies are distinct for each type of malignant hepatic tumors. However, the differential diagnosis before surgery is challenging and subjective. This study aims to build an automatic diagnostic model for differentiating malignant hepatic tumors based on patients’ multimodal medical data including multi-phase contrast-enhanced computed tomography and clinical features. Methods Our study consisted of 723 patients from two centers, who were pathologically diagnosed with HCC, ICC or metastatic liver cancer. The training set and the test set consisted of 499 and 113 patients from center 1, respectively. The external test set consisted of 111 patients from center 2. We proposed a deep learning model with the modular design of SpatialExtractor-TemporalEncoder-Integration-Classifier (STIC), which take the advantage of deep CNN and gated RNN to effectively extract and integrate the diagnosis-related radiological and clinical features of patients. The code is publicly available at https://github.com/ruitian-olivia/STIC-model . Results The STIC model achieved an accuracy of 86.2% and AUC of 0.893 for classifying HCC and ICC on the test set. When extended to differential diagnosis of malignant hepatic tumors, the STIC model achieved an accuracy of 72.6% on the test set, comparable with the diagnostic level of doctors’ consensus (70.8%). With the assistance of the STIC model, doctors achieved better performance than doctors’ consensus diagnosis, with an increase of 8.3% in accuracy and 26.9% in sensitivity for ICC diagnosis on average. On the external test set from center 2, the STIC model achieved an accuracy of 82.9%, which verify the model’s generalization ability. Conclusions We incorporated deep CNN and gated RNN in the STIC model design for differentiating malignant hepatic tumors based on multi-phase CECT and clinical features. Our model can assist doctors to achieve better diagnostic performance, which is expected to serve as an AI assistance system and promote the precise treatment of liver cancer.https://doi.org/10.1186/s13045-021-01167-2Artificial intelligenceLiver cancerContrast-enhanced CTComputer-assisted diagnosisMultimodal data |